Klebsiella Pneumoniae Infection Drug Market
1 Introduction to Research & Analysis Reports
1.1 Klebsiella Pneumoniae Infection Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Klebsiella Pneumoniae Infection Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Klebsiella Pneumoniae Infection Drug Overall Market Size
2.1 Global Klebsiella Pneumoniae Infection Drug Market Size: 2021 VS 2028
2.2 Global Klebsiella Pneumoniae Infection Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Klebsiella Pneumoniae Infection Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Klebsiella Pneumoniae Infection Drug Players in Global Market
3.2 Top Global Klebsiella Pneumoniae Infection Drug Companies Ranked by Revenue
3.3 Global Klebsiella Pneumoniae Infection Drug Revenue by Companies
3.4 Global Klebsiella Pneumoniae Infection Drug Sales by Companies
3.5 Global Klebsiella Pneumoniae Infection Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Klebsiella Pneumoniae Infection Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Klebsiella Pneumoniae Infection Drug Players in Global Market
3.8.1 List of Global Tier 1 Klebsiella Pneumoniae Infection Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Klebsiella Pneumoniae Infection Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Klebsiella Pneumoniae Infection Drug Market Size Markets, 2021 & 2028
4.1.2 ATI-1503
4.1.3 CA-824
4.1.4 CC-1807
4.1.5 Cefiderocol
4.1.6 Debio-1454
4.1.7 EBX-004
4.1.8 Others
4.2 By Type - Global Klebsiella Pneumoniae Infection Drug Revenue & Forecasts
4.2.1 By Type - Global Klebsiella Pneumoniae Infection Drug Revenue, 2017-2022
4.2.2 By Type - Global Klebsiella Pneumoniae Infection Drug Revenue, 2023-2028
4.2.3 By Type - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Klebsiella Pneumoniae Infection Drug Sales & Forecasts
4.3.1 By Type - Global Klebsiella Pneumoniae Infection Drug Sales, 2017-2022
4.3.2 By Type - Global Klebsiella Pneumoniae Infection Drug Sales, 2023-2028
4.3.3 By Type - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
4.4 By Type - Global Klebsiella Pneumoniae Infection Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Klebsiella Pneumoniae Infection Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Klebsiella Pneumoniae Infection Drug Revenue & Forecasts
5.2.1 By Application - Global Klebsiella Pneumoniae Infection Drug Revenue, 2017-2022
5.2.2 By Application - Global Klebsiella Pneumoniae Infection Drug Revenue, 2023-2028
5.2.3 By Application - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Klebsiella Pneumoniae Infection Drug Sales & Forecasts
5.3.1 By Application - Global Klebsiella Pneumoniae Infection Drug Sales, 2017-2022
5.3.2 By Application - Global Klebsiella Pneumoniae Infection Drug Sales, 2023-2028
5.3.3 By Application - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
5.4 By Application - Global Klebsiella Pneumoniae Infection Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Klebsiella Pneumoniae Infection Drug Market Size, 2021 & 2028
6.2 By Region - Global Klebsiella Pneumoniae Infection Drug Revenue & Forecasts
6.2.1 By Region - Global Klebsiella Pneumoniae Infection Drug Revenue, 2017-2022
6.2.2 By Region - Global Klebsiella Pneumoniae Infection Drug Revenue, 2023-2028
6.2.3 By Region - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Klebsiella Pneumoniae Infection Drug Sales & Forecasts
6.3.1 By Region - Global Klebsiella Pneumoniae Infection Drug Sales, 2017-2022
6.3.2 By Region - Global Klebsiella Pneumoniae Infection Drug Sales, 2023-2028
6.3.3 By Region - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028
6.4.2 By Country - North America Klebsiella Pneumoniae Infection Drug Sales, 2017-2028
6.4.3 US Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.4.4 Canada Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.4.5 Mexico Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028
6.5.2 By Country - Europe Klebsiella Pneumoniae Infection Drug Sales, 2017-2028
6.5.3 Germany Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.4 France Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.5 U.K. Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.6 Italy Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.7 Russia Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.8 Nordic Countries Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.5.9 Benelux Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028
6.6.2 By Region - Asia Klebsiella Pneumoniae Infection Drug Sales, 2017-2028
6.6.3 China Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.6.4 Japan Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.6.5 South Korea Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.6.6 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.6.7 India Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028
6.7.2 By Country - South America Klebsiella Pneumoniae Infection Drug Sales, 2017-2028
6.7.3 Brazil Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.7.4 Argentina Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales, 2017-2028
6.8.3 Turkey Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.8.4 Israel Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
6.8.6 UAE Klebsiella Pneumoniae Infection Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Acies Bio doo
7.1.1 Acies Bio doo Corporate Summary
7.1.2 Acies Bio doo Business Overview
7.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.1.5 Acies Bio doo Key News
7.2 Appili Therapeutics
7.2.1 Appili Therapeutics Corporate Summary
7.2.2 Appili Therapeutics Business Overview
7.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.2.5 Appili Therapeutics Key News
7.3 Debiopharm International SA
7.3.1 Debiopharm International SA Corporate Summary
7.3.2 Debiopharm International SA Business Overview
7.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.3.5 Debiopharm International SA Key News
7.4 Evaxion Biotech ApS
7.4.1 Evaxion Biotech ApS Corporate Summary
7.4.2 Evaxion Biotech ApS Business Overview
7.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.4.5 Evaxion Biotech ApS Key News
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd Key News
7.6 FOB Synthesis Inc
7.6.1 FOB Synthesis Inc Corporate Summary
7.6.2 FOB Synthesis Inc Business Overview
7.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.6.5 FOB Synthesis Inc Key News
7.7 ImmunoClin Corp
7.7.1 ImmunoClin Corp Corporate Summary
7.7.2 ImmunoClin Corp Business Overview
7.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.7.5 ImmunoClin Corp Key News
7.8 Innovation Pharmaceuticals Inc
7.8.1 Innovation Pharmaceuticals Inc Corporate Summary
7.8.2 Innovation Pharmaceuticals Inc Business Overview
7.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.8.5 Innovation Pharmaceuticals Inc Key News
7.9 Kyorin Pharmaceutical Co Ltd
7.9.1 Kyorin Pharmaceutical Co Ltd Corporate Summary
7.9.2 Kyorin Pharmaceutical Co Ltd Business Overview
7.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.9.5 Kyorin Pharmaceutical Co Ltd Key News
7.10 Melinta Therapeutics Inc
7.10.1 Melinta Therapeutics Inc Corporate Summary
7.10.2 Melinta Therapeutics Inc Business Overview
7.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.10.5 Melinta Therapeutics Inc Key News
7.11 Nosopharm SAS
7.11.1 Nosopharm SAS Corporate Summary
7.11.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Business Overview
7.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.11.4 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.11.5 Nosopharm SAS Key News
7.12 Peptilogics Inc
7.12.1 Peptilogics Inc Corporate Summary
7.12.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Business Overview
7.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.12.4 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.12.5 Peptilogics Inc Key News
7.13 Pfizer Inc
7.13.1 Pfizer Inc Corporate Summary
7.13.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Business Overview
7.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.13.4 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.13.5 Pfizer Inc Key News
7.14 Phico Therapeutics Ltd
7.14.1 Phico Therapeutics Ltd Corporate Summary
7.14.2 Phico Therapeutics Ltd Business Overview
7.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.14.4 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.14.5 Phico Therapeutics Ltd Key News
7.15 Sarepta Therapeutics Inc
7.15.1 Sarepta Therapeutics Inc Corporate Summary
7.15.2 Sarepta Therapeutics Inc Business Overview
7.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.15.4 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.15.5 Sarepta Therapeutics Inc Key News
7.16 Shionogi & Co Ltd
7.16.1 Shionogi & Co Ltd Corporate Summary
7.16.2 Shionogi & Co Ltd Business Overview
7.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.16.4 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.16.5 Shionogi & Co Ltd Key News
7.17 Syntiron LLC
7.17.1 Syntiron LLC Corporate Summary
7.17.2 Syntiron LLC Business Overview
7.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.17.4 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.17.5 Syntiron LLC Key News
7.18 Tetraphase Pharmaceuticals Inc
7.18.1 Tetraphase Pharmaceuticals Inc Corporate Summary
7.18.2 Tetraphase Pharmaceuticals Inc Business Overview
7.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Major Product Offerings
7.18.4 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales and Revenue in Global (2017-2022)
7.18.5 Tetraphase Pharmaceuticals Inc Key News
8 Global Klebsiella Pneumoniae Infection Drug Production Capacity, Analysis
8.1 Global Klebsiella Pneumoniae Infection Drug Production Capacity, 2017-2028
8.2 Klebsiella Pneumoniae Infection Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Klebsiella Pneumoniae Infection Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Klebsiella Pneumoniae Infection Drug Supply Chain Analysis
10.1 Klebsiella Pneumoniae Infection Drug Industry Value Chain
10.2 Klebsiella Pneumoniae Infection Drug Upstream Market
10.3 Klebsiella Pneumoniae Infection Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Klebsiella Pneumoniae Infection Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Klebsiella Pneumoniae Infection Drug in Global Market
Table 2. Top Klebsiella Pneumoniae Infection Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Klebsiella Pneumoniae Infection Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Companies, 2017-2022
Table 5. Global Klebsiella Pneumoniae Infection Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Klebsiella Pneumoniae Infection Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Klebsiella Pneumoniae Infection Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
Table 9. List of Global Tier 1 Klebsiella Pneumoniae Infection Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Klebsiella Pneumoniae Infection Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Klebsiella Pneumoniae Infection Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales, (K Pcs), 2023-2028
Table 46. Acies Bio doo Corporate Summary
Table 47. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offerings
Table 48. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Appili Therapeutics Corporate Summary
Table 50. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offerings
Table 51. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Debiopharm International SA Corporate Summary
Table 53. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offerings
Table 54. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Evaxion Biotech ApS Corporate Summary
Table 56. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offerings
Table 57. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. F. Hoffmann-La Roche Ltd Corporate Summary
Table 59. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offerings
Table 60. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. FOB Synthesis Inc Corporate Summary
Table 62. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 63. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. ImmunoClin Corp Corporate Summary
Table 65. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offerings
Table 66. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Innovation Pharmaceuticals Inc Corporate Summary
Table 68. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 69. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Kyorin Pharmaceutical Co Ltd Corporate Summary
Table 71. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offerings
Table 72. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Melinta Therapeutics Inc Corporate Summary
Table 74. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 75. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Nosopharm SAS Corporate Summary
Table 77. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offerings
Table 78. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Peptilogics Inc Corporate Summary
Table 80. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 81. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Pfizer Inc Corporate Summary
Table 83. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 84. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Phico Therapeutics Ltd Corporate Summary
Table 86. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offerings
Table 87. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Sarepta Therapeutics Inc Corporate Summary
Table 89. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 90. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Shionogi & Co Ltd Corporate Summary
Table 92. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offerings
Table 93. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Syntiron LLC Corporate Summary
Table 95. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offerings
Table 96. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Tetraphase Pharmaceuticals Inc Corporate Summary
Table 98. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offerings
Table 99. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Klebsiella Pneumoniae Infection Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 101. Global Klebsiella Pneumoniae Infection Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Klebsiella Pneumoniae Infection Drug Production by Region, 2017-2022 (K Pcs)
Table 103. Global Klebsiella Pneumoniae Infection Drug Production by Region, 2023-2028 (K Pcs)
Table 104. Klebsiella Pneumoniae Infection Drug Market Opportunities & Trends in Global Market
Table 105. Klebsiella Pneumoniae Infection Drug Market Drivers in Global Market
Table 106. Klebsiella Pneumoniae Infection Drug Market Restraints in Global Market
Table 107. Klebsiella Pneumoniae Infection Drug Raw Materials
Table 108. Klebsiella Pneumoniae Infection Drug Raw Materials Suppliers in Global Market
Table 109. Typical Klebsiella Pneumoniae Infection Drug Downstream
Table 110. Klebsiella Pneumoniae Infection Drug Downstream Clients in Global Market
Table 111. Klebsiella Pneumoniae Infection Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Klebsiella Pneumoniae Infection Drug Segment by Type
Figure 2. Klebsiella Pneumoniae Infection Drug Segment by Application
Figure 3. Global Klebsiella Pneumoniae Infection Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Klebsiella Pneumoniae Infection Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Klebsiella Pneumoniae Infection Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Klebsiella Pneumoniae Infection Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Klebsiella Pneumoniae Infection Drug Revenue in 2021
Figure 9. By Type - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 19. US Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 24. Germany Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 33. China Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 40. Brazil Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share, 2017-2028
Figure 44. Turkey Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Klebsiella Pneumoniae Infection Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Klebsiella Pneumoniae Infection Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Klebsiella Pneumoniae Infection Drug by Region, 2021 VS 2028
Figure 50. Klebsiella Pneumoniae Infection Drug Industry Value Chain
Figure 51. Marketing Channels